Literature DB >> 8772728

Abnormalities of retinal metabolism in diabetes or experimental galactosemia. III. Effects of antioxidants.

R A Kowluru1, T S Kern, R L Engerman, D Armstrong.   

Abstract

Effects of antioxidants on hyperglycemia-induced alterations of retinal metabolism were evaluated in rats diabetic or experimentally galactosemic for 2 months. Oxidative stress was estimated by measuring lipid peroxides (measured as thiobarbituric acid reactive substances [TBARS]) in retina and plasma. Erythrocyte osmotic fragility, another measure of oxidative stress, also was determined in the same groups of rats. In diabetic rats, TBARS were elevated by 74% in retina and 87% in plasma. In galactose-fed rats, TBARS were significantly elevated in retina (P < 0.05), but were normal in plasma. The administration of supplemental dietary ascorbic acid and alpha-tocopherol acetate for 2 months prevented the elevation of retinal TBARS and the decrease of Na(+)-K(+)-ATPase and calcium ATPase activities in retinas of diabetic animals without having any beneficial effect on plasma TBARS. In galactosemic rats, these antioxidants had a partial beneficial effect on the activity of retinal Na(+)-K(+)-ATPase, but failed to have any effect on calcium ATPase. The beneficial effects of antioxidants in diabetes and experimental galactosemia were not caused by the amelioration of hyperglycemia or retinal polyol accumulation. Erythrocyte osmotic fragility was increased by more than twofold in diabetes, but was normal in experimental galactosemia, and antioxidants prevented diabetes-induced increases in erythrocyte osmotic fragility-Diabetes-induced increased oxidative stress and subnormal ATPase activities in the retina can be inhibited by dietary supplementation with antioxidants.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8772728     DOI: 10.2337/diab.45.9.1233

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  31 in total

1.  Vulnerability of the retinal microvasculature to oxidative stress: ion channel-dependent mechanisms.

Authors:  Masanori Fukumoto; Atsuko Nakaizumi; Ting Zhang; Stephen I Lentz; Maho Shibata; Donald G Puro
Journal:  Am J Physiol Cell Physiol       Date:  2012-02-15       Impact factor: 4.249

2.  Catalase therapy corrects oxidative stress-induced pathophysiology in incipient diabetic retinopathy.

Authors:  Courtney R Giordano; Robin Roberts; Kendra A Krentz; David Bissig; Deepa Talreja; Ashok Kumar; Stanley R Terlecky; Bruce A Berkowitz
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-05       Impact factor: 4.799

Review 3.  Modulation of diabetic retinopathy pathophysiology by natural medicines through PPAR-γ-related pharmacology.

Authors:  Min K Song; Basil D Roufogalis; Tom H W Huang
Journal:  Br J Pharmacol       Date:  2012-01       Impact factor: 8.739

4.  Endurance training and glutathione-dependent antioxidant defense mechanism in heart of the diabetic rats.

Authors:  Mustafa Gül; Mustafa Atalay; Osmo Hänninen
Journal:  J Sports Sci Med       Date:  2003-06-01       Impact factor: 2.988

Review 5.  The significance of vascular and neural apoptosis to the pathology of diabetic retinopathy.

Authors:  Alistair J Barber; Thomas W Gardner; Steven F Abcouwer
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-02-28       Impact factor: 4.799

6.  Retinal ion regulation in a mouse model of diabetic retinopathy: natural history and the effect of Cu/Zn superoxide dismutase overexpression.

Authors:  Bruce A Berkowitz; Marius Gradianu; David Bissig; Timothy S Kern; Robin Roberts
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-12-13       Impact factor: 4.799

7.  Epigenetic modification of Sod2 in the development of diabetic retinopathy and in the metabolic memory: role of histone methylation.

Authors:  Qing Zhong; Renu A Kowluru
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-01-14       Impact factor: 4.799

8.  Prevention of retinal capillary basement membrane thickening in diabetic dogs by a non-steroidal anti-inflammatory drug.

Authors:  T A Gardiner; H R Anderson; T Degenhardt; S R Thorpe; J W Baynes; D B Archer; A W Stitt
Journal:  Diabetologia       Date:  2003-07-12       Impact factor: 10.122

9.  Matrix metalloproteinase-2 in the development of diabetic retinopathy and mitochondrial dysfunction.

Authors:  Ghulam Mohammad; Renu A Kowluru
Journal:  Lab Invest       Date:  2010-05-17       Impact factor: 5.662

10.  A compensatory mechanism protects retinal mitochondria from initial insult in diabetic retinopathy.

Authors:  Julia M Santos; Shikha Tewari; Renu A Kowluru
Journal:  Free Radic Biol Med       Date:  2012-09-01       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.